Purification and characterization of recombinant sTRAIL expressed in Escherichia coli

Acta Biochim Biophys Sin (Shanghai). 2004 Feb;36(2):118-22. doi: 10.1093/abbs/36.2.118.

Abstract

As a potential anti-tumor protein, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has drawn considerable attention. This report presented the purification and characterization of soluble TRAIL, expressed as inclusion bodies in E. coli. sTRAIL inclusion bodies were solubilized and refolded at a high concentration up to 0.9 g/L by a simple dilution method. Refolded protein was purified to electrophoretic homogeneity by a single-step immobilized metal affinity chromatography. The purified sTRAIL had a strong cytotoxic activity against human pancreatic tumor cell line 1990, with ED50 about 1.5 mg/L. Circular dichroism and fluorescence spectrum analysis showed that the refolded sTRAIL had a structure similar to that of native protein with beta-sheet secondary structure. This efficient procedure of sTRAIL renaturation may be useful for the mass production of this therapeutically important protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis Regulatory Proteins
  • Cell Line, Tumor
  • Chelating Agents / pharmacology
  • Chromatography, Affinity
  • Circular Dichroism
  • Dose-Response Relationship, Drug
  • Escherichia coli / metabolism*
  • Humans
  • Membrane Glycoproteins / chemistry*
  • Protein Conformation
  • Protein Folding
  • Protein Structure, Secondary
  • Recombinant Proteins / chemistry*
  • Spectrometry, Fluorescence
  • TNF-Related Apoptosis-Inducing Ligand
  • Time Factors
  • Tumor Necrosis Factor-alpha / chemistry*

Substances

  • Apoptosis Regulatory Proteins
  • Chelating Agents
  • Membrane Glycoproteins
  • Recombinant Proteins
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Tumor Necrosis Factor-alpha